
Tandem Diabetes Care TNDM
$ 19.82
-2.65%
Annual report 2025
added 02-19-2026
Tandem Diabetes Care Accounts Payables 2011-2026 | TNDM
Accounts payable — are the obligations of an organization to other legal entities or individuals that arise in cases when the company has acquired goods or services on deferred payment terms, has not paid taxes and fees, has wage arrears to employees, or has received loans and other liabilities. Accounts payable arise when an organization has already received some benefit but has not yet paid for it.Main types of accounts payable
| Type of liability | Example |
|---|---|
| To suppliers and contractors | Goods received but not yet paid for |
| Taxes and fees | VAT, income tax, etc., not paid on time |
| Salaries | Employee wages not paid |
| To budgets | Insurance contributions to funds not paid |
| To founders | Founders provided borrowed funds |
| To banks | Overdue loan payments |
| Other | Fines, penalties, forfeits, customer prepayments, etc. |
Impact on the company's financial performance
- Liquidity and solvency
Accounts payable are part of short-term liabilities, so they affect liquidity ratios - Financial stability
The higher the share of borrowed funds (including accounts payable), the lower the company's level of independence - Capital turnover
Moderate accounts payable can positively affect working capital by allowing the company to use “free” financing from suppliers (payment deferrals) - Risks and reputation
Large and especially overdue accounts payable may indicate financial difficulties. This can deter investors, partners, and lenders, and at a critical level of debt and lack of resources to repay it, bankruptcy proceedings may be initiated
Annual Accounts Payables Tandem Diabetes Care
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 47.1 M | 44.7 M | 49.6 M | 55.7 M | 28 M | 17.8 M | 17.7 M | 6.82 M | 5.15 M | 7.51 M | 5.23 M | 1.95 M | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 55.7 M | 1.95 M | 23.9 M |
Quarterly Accounts Payables Tandem Diabetes Care
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 47.5 M | 55.8 M | 59.8 M | 44.7 M | 48.8 M | 47.8 M | 48.1 M | 49.6 M | 46.1 M | 57.1 M | 55.2 M | 55.7 M | 61.5 M | - | 45.3 M | 28 M | 27 M | 27.5 M | 28.2 M | 17.8 M | 17.8 M | 17.8 M | 17.8 M | 17.7 M | 17.7 M | 17.7 M | 11.2 M | 6.82 M | 6.82 M | 6.82 M | 6.82 M | 5.15 M | 5.15 M | 5.15 M | 5.15 M | 7.51 M | 7.51 M | 7.51 M | 7.51 M | 5.23 M | 5.23 M | 5.23 M | 5.23 M | 1.95 M | 1.95 M | 1.95 M | 1.95 M | 2.35 M | 2.35 M | 2.35 M | 2.35 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 61.5 M | 1.95 M | 21.7 M |
Accounts Payables of other stocks in the Medical devices industry
| Issuer | Accounts Payables | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
AdaptHealth Corp.
AHCO
|
352 M | $ 13.08 | 2.19 % | $ 1.77 B | ||
|
Allied Healthcare Products
AHPI
|
1.21 M | - | 3.58 % | $ 2.21 M | ||
|
Avinger
AVGR
|
777 K | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
9.07 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
4.79 M | - | 1.37 % | $ 20.5 M | ||
|
BIOLASE
BIOL
|
6.06 M | - | -13.19 % | $ 166 K | ||
|
Conformis
CFMS
|
4.16 M | - | - | $ 16.4 M | ||
|
Cytosorbents Corporation
CTSO
|
2.87 M | $ 0.61 | -2.58 % | $ 38 M | ||
|
Apollo Endosurgery
APEN
|
7.42 M | - | - | $ 475 M | ||
|
EDAP TMS S.A.
EDAP
|
5.71 M | $ 3.22 | - | $ 121 M | ||
|
Cardiovascular Systems
CSII
|
14.4 M | - | 0.15 % | $ 844 M | ||
|
ClearPoint Neuro
CLPT
|
1.26 M | $ 11.21 | -4.84 % | $ 317 M | ||
|
Globus Medical
GMED
|
98.9 M | $ 93.7 | -1.24 % | $ 12.7 B | ||
|
Helius Medical Technologies
HSDT
|
531 K | $ 2.12 | -1.85 % | $ 1.29 M | ||
|
Dynatronics Corporation
DYNT
|
3.4 M | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
6.5 M | - | - | $ 10.2 M | ||
|
Electromed
ELMD
|
2.67 M | $ 26.0 | -1.48 % | $ 220 M | ||
|
Second Sight Medical Products
EYES
|
1.03 M | - | -0.97 % | $ 54.4 M | ||
|
GBS
GBS
|
1.47 M | - | -0.57 % | $ 7.12 M | ||
|
LivaNova PLC
LIVN
|
97.2 M | $ 63.41 | -1.23 % | $ 3.46 B | ||
|
LENSAR
LNSR
|
19 M | $ 5.21 | 2.36 % | $ 62.3 M | ||
|
Pulmonx Corporation
LUNG
|
3.9 M | $ 1.28 | 0.79 % | $ 52.1 M | ||
|
OrthoPediatrics Corp.
KIDS
|
18.8 M | $ 15.82 | -2.29 % | $ 371 M | ||
|
Butterfly Network
BFLY
|
4.25 M | $ 5.48 | 2.81 % | $ 1.16 B | ||
|
Insulet Corporation
PODD
|
75 M | $ 188.31 | -0.66 % | $ 13.2 B | ||
|
Delcath Systems
DCTH
|
2.66 M | $ 10.84 | - | $ 388 M | ||
|
IRIDEX Corporation
IRIX
|
5.38 M | $ 1.08 | 1.89 % | $ 18.3 M | ||
|
CONMED Corporation
CNMD
|
93.6 M | $ 37.87 | -1.23 % | $ 1.18 B | ||
|
Inspire Medical Systems
INSP
|
36.6 M | $ 55.07 | -2.2 % | $ 1.62 B | ||
|
Sintx Technologies
SINT
|
382 K | $ 2.35 | -4.86 % | $ 6.52 M | ||
|
Integer Holdings Corporation
ITGR
|
113 M | $ 85.35 | -0.78 % | $ 2.96 B | ||
|
PAVmed
PAVM
|
678 K | $ 8.4 | -6.67 % | $ 5.63 M | ||
|
Invacare Corporation
IVC
|
105 M | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
228 M | $ 83.46 | -0.94 % | $ 48.8 B | ||
|
Stryker Corporation
SYK
|
1.8 B | $ 329.01 | 0.46 % | $ 126 B | ||
|
MiMedx Group
MDXG
|
14.5 M | $ 3.34 | -2.62 % | $ 494 M | ||
|
Tactile Systems Technology
TCMD
|
4.97 M | $ 24.24 | -3.31 % | $ 554 M | ||
|
Nevro Corp.
NVRO
|
24.5 M | - | - | $ 217 M |